Literature DB >> 17952198

Familial polycythemia caused by a novel mutation in the beta globin gene: essential role of P50 in evaluation of familial polycythemia.

Neeraj Agarwal1, Mariluz P Mojica-Henshaw, Elizabeth D Simmons, Dottie Hussey, Ching N Ou, Josef T Prchal.   

Abstract

Two polycythemic subjects from a family with multiple polycythemic subjects were evaluated. Estimation of oxygen affinity of Hb from venous blood gas parameters (P50) revealed low P50 suggesting a high affinity Hb variant. Further work up, which included beta globin gene sequencing, revealed a novel mutation changing a codon to the previously reported high affinity Hb - Hb Johnstown (beta 109 Val->Leu). Polycythemic subjects with high affinity Hb variant are asymptomatic with normal life expectancy. Their differentiation from polycythemia vera (PV) is crucial to avoid therapy which is otherwise reserved for PV patients. We provide an electronic version (in Microsoft excel program) of a previously reported mathematical formula for rapid calculation of P50 from venous blood gases. Estimation of P50 is an essential initial step in the evaluation of a subject with personal and family history of polycythemia.

Entities:  

Keywords:  Estimation of P50; High affinity Hb; Polycythemia

Mesh:

Substances:

Year:  2007        PMID: 17952198      PMCID: PMC2016865          DOI: 10.7150/ijms.4.232

Source DB:  PubMed          Journal:  Int J Med Sci        ISSN: 1449-1907            Impact factor:   3.738


  13 in total

1.  Hb Johnstown [beta 109 (G11) Val-->Leu]: second case described and associated for the first time with beta(0)-thalassemia in two Spanish families.

Authors:  P Ropero; A Villegas; A F González; E Anguita; J Sánchez; D L Carreño; B Arrizabalaga; L Atuxta
Journal:  Am J Hematol       Date:  2000-12       Impact factor: 10.047

2.  Hb Johnstown [beta109(G11)Val-->Leu]: A high oxygen affinity variant associated with beta0-thalassemia.

Authors:  Aurora Feliu-Torres; Silvia Eandi Eberle; Ariel Roldán; Silvia González; Gabriela Sciuccati
Journal:  Hemoglobin       Date:  2004       Impact factor: 0.849

Review 3.  Hemoglobins with high oxygen affinity leading to erythrocytosis. New variants and new concepts.

Authors:  Henri Wajcman; Frederic Galactéros
Journal:  Hemoglobin       Date:  2005       Impact factor: 0.849

4.  HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update.

Authors:  Belinda Giardine; Sjozef van Baal; Polynikis Kaimakis; Cathy Riemer; Webb Miller; Maria Samara; Panagoula Kollia; Nicholas P Anagnou; David H K Chui; Henri Wajcman; Ross C Hardison; George P Patrinos
Journal:  Hum Mutat       Date:  2007-02       Impact factor: 4.878

5.  Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia.

Authors:  Sonny O Ang; Hua Chen; Kiichi Hirota; Victor R Gordeuk; Jaroslav Jelinek; Yongli Guan; Enli Liu; Adelina I Sergueeva; Galina Y Miasnikova; David Mole; Patrick H Maxwell; David W Stockton; Gregg L Semenza; Josef T Prchal
Journal:  Nat Genet       Date:  2002-11-04       Impact factor: 38.330

6.  Separation of peptides by high-pressure liquid chromatography for the identification of a hemoglobin variant.

Authors:  W A Schroeder; J B Shelton; J R Shelton; D Powars
Journal:  J Chromatogr       Date:  1979-07-01

7.  High-performance liquid chromatography of human hemoglobins on a new cation exchanger.

Authors:  C N Ou; G J Buffone; G L Reimer; A J Alpert
Journal:  J Chromatogr       Date:  1983-08-26

8.  Hb Johnstown [beta 109 (G11) Val----Leu]: a new electrophoretically silent variant that causes erythrocytosis.

Authors:  R T Jones; H I Saiontz; C Head; D T Shih; V F Fairbanks
Journal:  Hemoglobin       Date:  1990       Impact factor: 0.849

Review 9.  Congenital polycythemias/erythrocytoses.

Authors:  Victor R Gordeuk; David W Stockton; Josef T Prchal
Journal:  Haematologica       Date:  2005-01       Impact factor: 9.941

10.  Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

Authors:  Ayalew Tefferi; Juergen Thiele; Attilio Orazi; Hans Michael Kvasnicka; Tiziano Barbui; Curtis A Hanson; Giovanni Barosi; Srdan Verstovsek; Gunnar Birgegard; Ruben Mesa; John T Reilly; Heinz Gisslinger; Alessandro M Vannucchi; Francisco Cervantes; Guido Finazzi; Ronald Hoffman; D Gary Gilliland; Clara D Bloomfield; James W Vardiman
Journal:  Blood       Date:  2007-05-08       Impact factor: 22.113

View more
  6 in total

1.  Identification of high oxygen affinity hemoglobin variants in the investigation of patients with erythrocytosis.

Authors:  Melanie J Percy; Nauman N Butt; Gerard M Crotty; Mark W Drummond; Claire Harrison; Gail L Jones; Matthew Turner; Jonathan Wallis; Mary Frances McMullin
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

2.  Familial secondary erythrocytosis due to increased oxygen affinity is caused by destabilization of the T state of hemoglobin Brigham (α₂β₂(Pro100Leu)).

Authors:  Todd L Mollan; Bindu Abraham; Michael Brad Strader; Yiping Jia; Jay N Lozier; John S Olson; Abdu I Alayash
Journal:  Protein Sci       Date:  2012-08-21       Impact factor: 6.725

3.  Heterozygous Hemoglobin Sherwood Forest Causing Polycythemia.

Authors:  Vikram M Raghunathan; James N Butera; Diana O Treaba
Journal:  Case Rep Hematol       Date:  2017-09-28

Review 4.  JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views.

Authors:  Naseema Gangat; Natasha Szuber; Animesh Pardanani; Ayalew Tefferi
Journal:  Leukemia       Date:  2021-05-21       Impact factor: 11.528

5.  Benign familial polycythaemia in a young male.

Authors:  Maitra Somnath; Bhowmik Sreejita
Journal:  Hematol Rep       Date:  2012-01-10

6.  Raised HIF1α during normoxia in high altitude pulmonary edema susceptible non-mountaineers.

Authors:  Poonam Soree; Rajinder K Gupta; Krishan Singh; Koundinya Desiraju; Anurag Agrawal; Praveen Vats; Abhishek Bharadwaj; T P Baburaj; Pooja Chaudhary; Vijay K Singh; Saroj Verma; Amir Chand Bajaj; Shashi Bala Singh
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.